Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception.
The angiopoietins (Ang) are endothelial cell-related factors necessary for the development and maintenance of all vessels. Altering the expression of these proteins would be expected to result in aberrant angiogenesis. Indeed the fragile endometrial vasculature and bleeding observed in women treated with long-term progestin-only contraceptives has been associated with changes in the expression of Ang-1 and Ang-2. Since bleeding would result in thrombin formation, we have assessed the effects of thrombin on the expression of the Angs in human endometrial cells. This study shows that thrombin significantly reduces the expression of Ang-1 protein and mRNA expression in human endometrial stromal cells (HESCs) and minimally decreases the production of Ang-2 protein in human endometrial endothelial cells (HEECs). Hence the presence of thrombin due to aberrant bleeding could affect the angiogenic potential of the endometrium, creating a feed forward loop resulting in more thrombin, weak vasculature, and more bleeding. In addition, since the exact localization of Ang in the human endometrium remains a subject of controversy, we have addressed this issue in an in vivo system by analyzing the expression of Angs by microdissection of HESCs, HEECs, and human endometrial glandular epithelial cells followed by real time, quantitative RT-PCR.
Krikun
Graciela
G
Department of Obstetrics, Yale University, School of Medicine, New Haven, Connecticut 06520-8063, USA. graciela.krikun@yale.edu
Sakkas
Denny
D
Schatz
Frederick
F
Buchwalder
Lynn
L
Hylton
Donna
D
Tang
Caroline
C
Lockwood
Charles J
CJ
D042683:Angiopoietin-1 / Q000235:genetics*; D042702:Angiopoietin-2 / Q000235:genetics*; D002478:Cells, Cultured; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004210:Dissection / Q000379:methods; D004717:Endometrium / Q000098:blood supply / Q000473:pathology / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics*; D012739:Gonadal Steroid Hormones / Q000494:pharmacology*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000139:chemically induced* / Q000235:genetics* / Q000473:pathology; D011372:Progestins / Q000009:adverse effects*; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017154:Stromal Cells / Q000166:cytology / Q000473:pathology; D013917:Thrombin / Q000494:pharmacology*
D042683:Angiopoietin-1; D042702:Angiopoietin-2; D003276:Contraceptives, Oral; D012739:Gonadal Steroid Hormones; D011372:Progestins; D012333:RNA, Messenger; D013917:Thrombin